Global Opioid Induced Constipation (OIC) Drug Market Growth 2025-2031
The global Opioid Induced Constipation (OIC) Drug market size is predicted to grow from US$ 2827 million in 2025 to US$ 3740 million in 2031; it is expected to grow at a CAGR of 4.8% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Opioid Induced Constipation (OIC) Drug Industry Forecast? looks at past sales and reviews total world Opioid Induced Constipation (OIC) Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Opioid Induced Constipation (OIC) Drug sales for 2025 through 2031. With Opioid Induced Constipation (OIC) Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Opioid Induced Constipation (OIC) Drug industry.
This Insight Report provides a comprehensive analysis of the global Opioid Induced Constipation (OIC) Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Opioid Induced Constipation (OIC) Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Opioid Induced Constipation (OIC) Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Opioid Induced Constipation (OIC) Drug and breaks down the forecast by Type, by Distribution Channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Opioid Induced Constipation (OIC) Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Opioid Induced Constipation (OIC) Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Opioid Induced Constipation (OIC) Drug market?
What factors are driving Opioid Induced Constipation (OIC) Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Opioid Induced Constipation (OIC) Drug market opportunities vary by end market size?
How does Opioid Induced Constipation (OIC) Drug break out by Type, by Distribution Channel?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Opioid Induced Constipation (OIC) Drug Industry Forecast? looks at past sales and reviews total world Opioid Induced Constipation (OIC) Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Opioid Induced Constipation (OIC) Drug sales for 2025 through 2031. With Opioid Induced Constipation (OIC) Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Opioid Induced Constipation (OIC) Drug industry.
This Insight Report provides a comprehensive analysis of the global Opioid Induced Constipation (OIC) Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Opioid Induced Constipation (OIC) Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Opioid Induced Constipation (OIC) Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Opioid Induced Constipation (OIC) Drug and breaks down the forecast by Type, by Distribution Channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Opioid Induced Constipation (OIC) Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Opioid Induced Constipation (OIC) Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Lubiprostone
- Methyl Naltrexone Bromide
- Naldemedine
- Alvimopan
- Other
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Ironwood Pharmaceuticals
- Daiichi Sankyo Co
- Pfizer
- Progenics Pharmaceuticals
- Shionogi &
- Allergan
- Nektar Therapeutics
- Purdue Pharma
- S.L.A. Pharma
- Mundipharma International Limited
- Ono Pharmaceutical
- Takeda Pharmaceutical Company Limited
- Theravance Biopharma
- Bausch Health
- Cosmo Pharmaceuticals SA
- Daewoong Pharmaceutical
- C.B. Fleet Company
- Sucampo Pharmaceuticals
What is the 10-year outlook for the global Opioid Induced Constipation (OIC) Drug market?
What factors are driving Opioid Induced Constipation (OIC) Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Opioid Induced Constipation (OIC) Drug market opportunities vary by end market size?
How does Opioid Induced Constipation (OIC) Drug break out by Type, by Distribution Channel?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Opioid Induced Constipation (OIC) Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Opioid Induced Constipation (OIC) Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Opioid Induced Constipation (OIC) Drug by Country/Region, 2020, 2024 & 2031
2.2 Opioid Induced Constipation (OIC) Drug Segment by Type
2.2.1 Lubiprostone
2.2.2 Methyl Naltrexone Bromide
2.2.3 Naldemedine
2.2.4 Alvimopan
2.2.5 Other
2.3 Opioid Induced Constipation (OIC) Drug Sales by Type
2.3.1 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Opioid Induced Constipation (OIC) Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Opioid Induced Constipation (OIC) Drug Sale Price by Type (2020-2025)
2.4 Opioid Induced Constipation (OIC) Drug Segment by Distribution Channel
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel
2.5.1 Global Opioid Induced Constipation (OIC) Drug Sale Market Share by Distribution Channel (2020-2025)
2.5.2 Global Opioid Induced Constipation (OIC) Drug Revenue and Market Share by Distribution Channel (2020-2025)
2.5.3 Global Opioid Induced Constipation (OIC) Drug Sale Price by Distribution Channel (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Opioid Induced Constipation (OIC) Drug Breakdown Data by Company
3.1.1 Global Opioid Induced Constipation (OIC) Drug Annual Sales by Company (2020-2025)
3.1.2 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Company (2020-2025)
3.2 Global Opioid Induced Constipation (OIC) Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Opioid Induced Constipation (OIC) Drug Revenue by Company (2020-2025)
3.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Company (2020-2025)
3.3 Global Opioid Induced Constipation (OIC) Drug Sale Price by Company
3.4 Key Manufacturers Opioid Induced Constipation (OIC) Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioid Induced Constipation (OIC) Drug Product Location Distribution
3.4.2 Players Opioid Induced Constipation (OIC) Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR OPIOID INDUCED CONSTIPATION (OIC) DRUG BY GEOGRAPHIC REGION
4.1 World Historic Opioid Induced Constipation (OIC) Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Opioid Induced Constipation (OIC) Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Opioid Induced Constipation (OIC) Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Opioid Induced Constipation (OIC) Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Opioid Induced Constipation (OIC) Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Opioid Induced Constipation (OIC) Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Opioid Induced Constipation (OIC) Drug Sales Growth
4.4 APAC Opioid Induced Constipation (OIC) Drug Sales Growth
4.5 Europe Opioid Induced Constipation (OIC) Drug Sales Growth
4.6 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Growth
5 AMERICAS
5.1 Americas Opioid Induced Constipation (OIC) Drug Sales by Country
5.1.1 Americas Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2025)
5.1.2 Americas Opioid Induced Constipation (OIC) Drug Revenue by Country (2020-2025)
5.2 Americas Opioid Induced Constipation (OIC) Drug Sales by Type (2020-2025)
5.3 Americas Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioid Induced Constipation (OIC) Drug Sales by Region
6.1.1 APAC Opioid Induced Constipation (OIC) Drug Sales by Region (2020-2025)
6.1.2 APAC Opioid Induced Constipation (OIC) Drug Revenue by Region (2020-2025)
6.2 APAC Opioid Induced Constipation (OIC) Drug Sales by Type (2020-2025)
6.3 APAC Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Opioid Induced Constipation (OIC) Drug by Country
7.1.1 Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2025)
7.1.2 Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2020-2025)
7.2 Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2020-2025)
7.3 Europe Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Opioid Induced Constipation (OIC) Drug by Country
8.1.1 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Opioid Induced Constipation (OIC) Drug
10.3 Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drug
10.4 Industry Chain Structure of Opioid Induced Constipation (OIC) Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Opioid Induced Constipation (OIC) Drug Distributors
11.3 Opioid Induced Constipation (OIC) Drug Customer
12 WORLD FORECAST REVIEW FOR OPIOID INDUCED CONSTIPATION (OIC) DRUG BY GEOGRAPHIC REGION
12.1 Global Opioid Induced Constipation (OIC) Drug Market Size Forecast by Region
12.1.1 Global Opioid Induced Constipation (OIC) Drug Forecast by Region (2026-2031)
12.1.2 Global Opioid Induced Constipation (OIC) Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Opioid Induced Constipation (OIC) Drug Forecast by Type (2026-2031)
12.7 Global Opioid Induced Constipation (OIC) Drug Forecast by Distribution Channel (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Ironwood Pharmaceuticals
13.1.1 Ironwood Pharmaceuticals Company Information
13.1.2 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.1.3 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Ironwood Pharmaceuticals Main Business Overview
13.1.5 Ironwood Pharmaceuticals Latest Developments
13.2 Daiichi Sankyo Co
13.2.1 Daiichi Sankyo Co Company Information
13.2.2 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.2.3 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Daiichi Sankyo Co Main Business Overview
13.2.5 Daiichi Sankyo Co Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.3.3 Pfizer Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Progenics Pharmaceuticals
13.4.1 Progenics Pharmaceuticals Company Information
13.4.2 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.4.3 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Progenics Pharmaceuticals Main Business Overview
13.4.5 Progenics Pharmaceuticals Latest Developments
13.5 Shionogi &
13.5.1 Shionogi & Company Information
13.5.2 Shionogi & Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.5.3 Shionogi & Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Shionogi & Main Business Overview
13.5.5 Shionogi & Latest Developments
13.6 Allergan
13.6.1 Allergan Company Information
13.6.2 Allergan Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.6.3 Allergan Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Allergan Main Business Overview
13.6.5 Allergan Latest Developments
13.7 Nektar Therapeutics
13.7.1 Nektar Therapeutics Company Information
13.7.2 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Nektar Therapeutics Main Business Overview
13.7.5 Nektar Therapeutics Latest Developments
13.8 Purdue Pharma
13.8.1 Purdue Pharma Company Information
13.8.2 Purdue Pharma Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Purdue Pharma Main Business Overview
13.8.5 Purdue Pharma Latest Developments
13.9 S.L.A. Pharma
13.9.1 S.L.A. Pharma Company Information
13.9.2 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.9.3 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 S.L.A. Pharma Main Business Overview
13.9.5 S.L.A. Pharma Latest Developments
13.10 Mundipharma International Limited
13.10.1 Mundipharma International Limited Company Information
13.10.2 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Mundipharma International Limited Main Business Overview
13.10.5 Mundipharma International Limited Latest Developments
13.11 Ono Pharmaceutical
13.11.1 Ono Pharmaceutical Company Information
13.11.2 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.11.3 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Ono Pharmaceutical Main Business Overview
13.11.5 Ono Pharmaceutical Latest Developments
13.12 Takeda Pharmaceutical Company Limited
13.12.1 Takeda Pharmaceutical Company Limited Company Information
13.12.2 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Takeda Pharmaceutical Company Limited Main Business Overview
13.12.5 Takeda Pharmaceutical Company Limited Latest Developments
13.13 Theravance Biopharma
13.13.1 Theravance Biopharma Company Information
13.13.2 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.13.3 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Theravance Biopharma Main Business Overview
13.13.5 Theravance Biopharma Latest Developments
13.14 Bausch Health
13.14.1 Bausch Health Company Information
13.14.2 Bausch Health Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.14.3 Bausch Health Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Bausch Health Main Business Overview
13.14.5 Bausch Health Latest Developments
13.15 Cosmo Pharmaceuticals SA
13.15.1 Cosmo Pharmaceuticals SA Company Information
13.15.2 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Cosmo Pharmaceuticals SA Main Business Overview
13.15.5 Cosmo Pharmaceuticals SA Latest Developments
13.16 Daewoong Pharmaceutical
13.16.1 Daewoong Pharmaceutical Company Information
13.16.2 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Daewoong Pharmaceutical Main Business Overview
13.16.5 Daewoong Pharmaceutical Latest Developments
13.17 C.B. Fleet Company
13.17.1 C.B. Fleet Company Company Information
13.17.2 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 C.B. Fleet Company Main Business Overview
13.17.5 C.B. Fleet Company Latest Developments
13.18 Sucampo Pharmaceuticals
13.18.1 Sucampo Pharmaceuticals Company Information
13.18.2 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Sucampo Pharmaceuticals Main Business Overview
13.18.5 Sucampo Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Opioid Induced Constipation (OIC) Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Opioid Induced Constipation (OIC) Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Opioid Induced Constipation (OIC) Drug by Country/Region, 2020, 2024 & 2031
2.2 Opioid Induced Constipation (OIC) Drug Segment by Type
2.2.1 Lubiprostone
2.2.2 Methyl Naltrexone Bromide
2.2.3 Naldemedine
2.2.4 Alvimopan
2.2.5 Other
2.3 Opioid Induced Constipation (OIC) Drug Sales by Type
2.3.1 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Opioid Induced Constipation (OIC) Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Opioid Induced Constipation (OIC) Drug Sale Price by Type (2020-2025)
2.4 Opioid Induced Constipation (OIC) Drug Segment by Distribution Channel
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel
2.5.1 Global Opioid Induced Constipation (OIC) Drug Sale Market Share by Distribution Channel (2020-2025)
2.5.2 Global Opioid Induced Constipation (OIC) Drug Revenue and Market Share by Distribution Channel (2020-2025)
2.5.3 Global Opioid Induced Constipation (OIC) Drug Sale Price by Distribution Channel (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Opioid Induced Constipation (OIC) Drug Breakdown Data by Company
3.1.1 Global Opioid Induced Constipation (OIC) Drug Annual Sales by Company (2020-2025)
3.1.2 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Company (2020-2025)
3.2 Global Opioid Induced Constipation (OIC) Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Opioid Induced Constipation (OIC) Drug Revenue by Company (2020-2025)
3.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Company (2020-2025)
3.3 Global Opioid Induced Constipation (OIC) Drug Sale Price by Company
3.4 Key Manufacturers Opioid Induced Constipation (OIC) Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioid Induced Constipation (OIC) Drug Product Location Distribution
3.4.2 Players Opioid Induced Constipation (OIC) Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR OPIOID INDUCED CONSTIPATION (OIC) DRUG BY GEOGRAPHIC REGION
4.1 World Historic Opioid Induced Constipation (OIC) Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Opioid Induced Constipation (OIC) Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Opioid Induced Constipation (OIC) Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Opioid Induced Constipation (OIC) Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Opioid Induced Constipation (OIC) Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Opioid Induced Constipation (OIC) Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Opioid Induced Constipation (OIC) Drug Sales Growth
4.4 APAC Opioid Induced Constipation (OIC) Drug Sales Growth
4.5 Europe Opioid Induced Constipation (OIC) Drug Sales Growth
4.6 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Growth
5 AMERICAS
5.1 Americas Opioid Induced Constipation (OIC) Drug Sales by Country
5.1.1 Americas Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2025)
5.1.2 Americas Opioid Induced Constipation (OIC) Drug Revenue by Country (2020-2025)
5.2 Americas Opioid Induced Constipation (OIC) Drug Sales by Type (2020-2025)
5.3 Americas Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioid Induced Constipation (OIC) Drug Sales by Region
6.1.1 APAC Opioid Induced Constipation (OIC) Drug Sales by Region (2020-2025)
6.1.2 APAC Opioid Induced Constipation (OIC) Drug Revenue by Region (2020-2025)
6.2 APAC Opioid Induced Constipation (OIC) Drug Sales by Type (2020-2025)
6.3 APAC Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Opioid Induced Constipation (OIC) Drug by Country
7.1.1 Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2025)
7.1.2 Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2020-2025)
7.2 Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2020-2025)
7.3 Europe Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Opioid Induced Constipation (OIC) Drug by Country
8.1.1 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Opioid Induced Constipation (OIC) Drug
10.3 Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drug
10.4 Industry Chain Structure of Opioid Induced Constipation (OIC) Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Opioid Induced Constipation (OIC) Drug Distributors
11.3 Opioid Induced Constipation (OIC) Drug Customer
12 WORLD FORECAST REVIEW FOR OPIOID INDUCED CONSTIPATION (OIC) DRUG BY GEOGRAPHIC REGION
12.1 Global Opioid Induced Constipation (OIC) Drug Market Size Forecast by Region
12.1.1 Global Opioid Induced Constipation (OIC) Drug Forecast by Region (2026-2031)
12.1.2 Global Opioid Induced Constipation (OIC) Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Opioid Induced Constipation (OIC) Drug Forecast by Type (2026-2031)
12.7 Global Opioid Induced Constipation (OIC) Drug Forecast by Distribution Channel (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Ironwood Pharmaceuticals
13.1.1 Ironwood Pharmaceuticals Company Information
13.1.2 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.1.3 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Ironwood Pharmaceuticals Main Business Overview
13.1.5 Ironwood Pharmaceuticals Latest Developments
13.2 Daiichi Sankyo Co
13.2.1 Daiichi Sankyo Co Company Information
13.2.2 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.2.3 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Daiichi Sankyo Co Main Business Overview
13.2.5 Daiichi Sankyo Co Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.3.3 Pfizer Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Progenics Pharmaceuticals
13.4.1 Progenics Pharmaceuticals Company Information
13.4.2 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.4.3 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Progenics Pharmaceuticals Main Business Overview
13.4.5 Progenics Pharmaceuticals Latest Developments
13.5 Shionogi &
13.5.1 Shionogi & Company Information
13.5.2 Shionogi & Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.5.3 Shionogi & Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Shionogi & Main Business Overview
13.5.5 Shionogi & Latest Developments
13.6 Allergan
13.6.1 Allergan Company Information
13.6.2 Allergan Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.6.3 Allergan Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Allergan Main Business Overview
13.6.5 Allergan Latest Developments
13.7 Nektar Therapeutics
13.7.1 Nektar Therapeutics Company Information
13.7.2 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Nektar Therapeutics Main Business Overview
13.7.5 Nektar Therapeutics Latest Developments
13.8 Purdue Pharma
13.8.1 Purdue Pharma Company Information
13.8.2 Purdue Pharma Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Purdue Pharma Main Business Overview
13.8.5 Purdue Pharma Latest Developments
13.9 S.L.A. Pharma
13.9.1 S.L.A. Pharma Company Information
13.9.2 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.9.3 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 S.L.A. Pharma Main Business Overview
13.9.5 S.L.A. Pharma Latest Developments
13.10 Mundipharma International Limited
13.10.1 Mundipharma International Limited Company Information
13.10.2 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Mundipharma International Limited Main Business Overview
13.10.5 Mundipharma International Limited Latest Developments
13.11 Ono Pharmaceutical
13.11.1 Ono Pharmaceutical Company Information
13.11.2 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.11.3 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Ono Pharmaceutical Main Business Overview
13.11.5 Ono Pharmaceutical Latest Developments
13.12 Takeda Pharmaceutical Company Limited
13.12.1 Takeda Pharmaceutical Company Limited Company Information
13.12.2 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Takeda Pharmaceutical Company Limited Main Business Overview
13.12.5 Takeda Pharmaceutical Company Limited Latest Developments
13.13 Theravance Biopharma
13.13.1 Theravance Biopharma Company Information
13.13.2 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.13.3 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Theravance Biopharma Main Business Overview
13.13.5 Theravance Biopharma Latest Developments
13.14 Bausch Health
13.14.1 Bausch Health Company Information
13.14.2 Bausch Health Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.14.3 Bausch Health Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Bausch Health Main Business Overview
13.14.5 Bausch Health Latest Developments
13.15 Cosmo Pharmaceuticals SA
13.15.1 Cosmo Pharmaceuticals SA Company Information
13.15.2 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Cosmo Pharmaceuticals SA Main Business Overview
13.15.5 Cosmo Pharmaceuticals SA Latest Developments
13.16 Daewoong Pharmaceutical
13.16.1 Daewoong Pharmaceutical Company Information
13.16.2 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Daewoong Pharmaceutical Main Business Overview
13.16.5 Daewoong Pharmaceutical Latest Developments
13.17 C.B. Fleet Company
13.17.1 C.B. Fleet Company Company Information
13.17.2 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 C.B. Fleet Company Main Business Overview
13.17.5 C.B. Fleet Company Latest Developments
13.18 Sucampo Pharmaceuticals
13.18.1 Sucampo Pharmaceuticals Company Information
13.18.2 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
13.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Sucampo Pharmaceuticals Main Business Overview
13.18.5 Sucampo Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Opioid Induced Constipation (OIC) Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Opioid Induced Constipation (OIC) Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Lubiprostone
Table 4. Major Players of Methyl Naltrexone Bromide
Table 5. Major Players of Naldemedine
Table 6. Major Players of Alvimopan
Table 7. Major Players of Other
Table 8. Global Opioid Induced Constipation (OIC) Drug Sales by Type (2020-2025) & (K Units)
Table 9. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2020-2025)
Table 10. Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2020-2025) & ($ million)
Table 11. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2020-2025)
Table 12. Global Opioid Induced Constipation (OIC) Drug Sale Price by Type (2020-2025) & (USD/Unit)
Table 13. Global Opioid Induced Constipation (OIC) Drug Sale by Distribution Channel (2020-2025) & (K Units)
Table 14. Global Opioid Induced Constipation (OIC) Drug Sale Market Share by Distribution Channel (2020-2025)
Table 15. Global Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2020-2025) & ($ million)
Table 16. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel (2020-2025)
Table 17. Global Opioid Induced Constipation (OIC) Drug Sale Price by Distribution Channel (2020-2025) & (USD/Unit)
Table 18. Global Opioid Induced Constipation (OIC) Drug Sales by Company (2020-2025) & (K Units)
Table 19. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Company (2020-2025)
Table 20. Global Opioid Induced Constipation (OIC) Drug Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Company (2020-2025)
Table 22. Global Opioid Induced Constipation (OIC) Drug Sale Price by Company (2020-2025) & (USD/Unit)
Table 23. Key Manufacturers Opioid Induced Constipation (OIC) Drug Producing Area Distribution and Sales Area
Table 24. Players Opioid Induced Constipation (OIC) Drug Products Offered
Table 25. Opioid Induced Constipation (OIC) Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Opioid Induced Constipation (OIC) Drug Sales by Geographic Region (2020-2025) & (K Units)
Table 29. Global Opioid Induced Constipation (OIC) Drug Sales Market Share Geographic Region (2020-2025)
Table 30. Global Opioid Induced Constipation (OIC) Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Opioid Induced Constipation (OIC) Drug Sales by Country/Region (2020-2025) & (K Units)
Table 33. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Country/Region (2020-2025)
Table 34. Global Opioid Induced Constipation (OIC) Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2025) & (K Units)
Table 37. Americas Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2020-2025)
Table 38. Americas Opioid Induced Constipation (OIC) Drug Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Opioid Induced Constipation (OIC) Drug Sales by Type (2020-2025) & (K Units)
Table 40. Americas Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2020-2025) & (K Units)
Table 41. APAC Opioid Induced Constipation (OIC) Drug Sales by Region (2020-2025) & (K Units)
Table 42. APAC Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2020-2025)
Table 43. APAC Opioid Induced Constipation (OIC) Drug Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Opioid Induced Constipation (OIC) Drug Sales by Type (2020-2025) & (K Units)
Table 45. APAC Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2020-2025) & (K Units)
Table 46. Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2025) & (K Units)
Table 47. Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2020-2025) & (K Units)
Table 49. Europe Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2020-2025) & (K Units)
Table 50. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2025) & (K Units)
Table 51. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Type (2020-2025) & (K Units)
Table 53. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2020-2025) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Opioid Induced Constipation (OIC) Drug
Table 55. Key Market Challenges & Risks of Opioid Induced Constipation (OIC) Drug
Table 56. Key Industry Trends of Opioid Induced Constipation (OIC) Drug
Table 57. Opioid Induced Constipation (OIC) Drug Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Opioid Induced Constipation (OIC) Drug Distributors List
Table 60. Opioid Induced Constipation (OIC) Drug Customer List
Table 61. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 62. Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 64. Americas Opioid Induced Constipation (OIC) Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Opioid Induced Constipation (OIC) Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 66. APAC Opioid Induced Constipation (OIC) Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Europe Opioid Induced Constipation (OIC) Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 70. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Type (2026-2031) & (K Units)
Table 72. Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Distribution Channel (2026-2031) & (K Units)
Table 74. Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Distribution Channel (2026-2031) & ($ millions)
Table 75. Ironwood Pharmaceuticals Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 76. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 77. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Ironwood Pharmaceuticals Main Business
Table 79. Ironwood Pharmaceuticals Latest Developments
Table 80. Daiichi Sankyo Co Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 81. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 82. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Daiichi Sankyo Co Main Business
Table 84. Daiichi Sankyo Co Latest Developments
Table 85. Pfizer Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 86. Pfizer Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 87. Pfizer Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Pfizer Main Business
Table 89. Pfizer Latest Developments
Table 90. Progenics Pharmaceuticals Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 91. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 92. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Progenics Pharmaceuticals Main Business
Table 94. Progenics Pharmaceuticals Latest Developments
Table 95. Shionogi & Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. Shionogi & Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 97. Shionogi & Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Shionogi & Main Business
Table 99. Shionogi & Latest Developments
Table 100. Allergan Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. Allergan Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 102. Allergan Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Allergan Main Business
Table 104. Allergan Latest Developments
Table 105. Nektar Therapeutics Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 106. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 107. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Nektar Therapeutics Main Business
Table 109. Nektar Therapeutics Latest Developments
Table 110. Purdue Pharma Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 111. Purdue Pharma Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 112. Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Purdue Pharma Main Business
Table 114. Purdue Pharma Latest Developments
Table 115. S.L.A. Pharma Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 116. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 117. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. S.L.A. Pharma Main Business
Table 119. S.L.A. Pharma Latest Developments
Table 120. Mundipharma International Limited Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 121. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 122. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Mundipharma International Limited Main Business
Table 124. Mundipharma International Limited Latest Developments
Table 125. Ono Pharmaceutical Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 126. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 127. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Ono Pharmaceutical Main Business
Table 129. Ono Pharmaceutical Latest Developments
Table 130. Takeda Pharmaceutical Company Limited Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 131. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 132. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Takeda Pharmaceutical Company Limited Main Business
Table 134. Takeda Pharmaceutical Company Limited Latest Developments
Table 135. Theravance Biopharma Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 136. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 137. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Theravance Biopharma Main Business
Table 139. Theravance Biopharma Latest Developments
Table 140. Bausch Health Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 141. Bausch Health Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 142. Bausch Health Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Bausch Health Main Business
Table 144. Bausch Health Latest Developments
Table 145. Cosmo Pharmaceuticals SA Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 146. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 147. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Cosmo Pharmaceuticals SA Main Business
Table 149. Cosmo Pharmaceuticals SA Latest Developments
Table 150. Daewoong Pharmaceutical Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 151. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 152. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Daewoong Pharmaceutical Main Business
Table 154. Daewoong Pharmaceutical Latest Developments
Table 155. C.B. Fleet Company Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 156. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 157. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. C.B. Fleet Company Main Business
Table 159. C.B. Fleet Company Latest Developments
Table 160. Sucampo Pharmaceuticals Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 161. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 162. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. Sucampo Pharmaceuticals Main Business
Table 164. Sucampo Pharmaceuticals Latest Developments
Table 1. Opioid Induced Constipation (OIC) Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Opioid Induced Constipation (OIC) Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Lubiprostone
Table 4. Major Players of Methyl Naltrexone Bromide
Table 5. Major Players of Naldemedine
Table 6. Major Players of Alvimopan
Table 7. Major Players of Other
Table 8. Global Opioid Induced Constipation (OIC) Drug Sales by Type (2020-2025) & (K Units)
Table 9. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2020-2025)
Table 10. Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2020-2025) & ($ million)
Table 11. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2020-2025)
Table 12. Global Opioid Induced Constipation (OIC) Drug Sale Price by Type (2020-2025) & (USD/Unit)
Table 13. Global Opioid Induced Constipation (OIC) Drug Sale by Distribution Channel (2020-2025) & (K Units)
Table 14. Global Opioid Induced Constipation (OIC) Drug Sale Market Share by Distribution Channel (2020-2025)
Table 15. Global Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2020-2025) & ($ million)
Table 16. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel (2020-2025)
Table 17. Global Opioid Induced Constipation (OIC) Drug Sale Price by Distribution Channel (2020-2025) & (USD/Unit)
Table 18. Global Opioid Induced Constipation (OIC) Drug Sales by Company (2020-2025) & (K Units)
Table 19. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Company (2020-2025)
Table 20. Global Opioid Induced Constipation (OIC) Drug Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Company (2020-2025)
Table 22. Global Opioid Induced Constipation (OIC) Drug Sale Price by Company (2020-2025) & (USD/Unit)
Table 23. Key Manufacturers Opioid Induced Constipation (OIC) Drug Producing Area Distribution and Sales Area
Table 24. Players Opioid Induced Constipation (OIC) Drug Products Offered
Table 25. Opioid Induced Constipation (OIC) Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Opioid Induced Constipation (OIC) Drug Sales by Geographic Region (2020-2025) & (K Units)
Table 29. Global Opioid Induced Constipation (OIC) Drug Sales Market Share Geographic Region (2020-2025)
Table 30. Global Opioid Induced Constipation (OIC) Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Opioid Induced Constipation (OIC) Drug Sales by Country/Region (2020-2025) & (K Units)
Table 33. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Country/Region (2020-2025)
Table 34. Global Opioid Induced Constipation (OIC) Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2025) & (K Units)
Table 37. Americas Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2020-2025)
Table 38. Americas Opioid Induced Constipation (OIC) Drug Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Opioid Induced Constipation (OIC) Drug Sales by Type (2020-2025) & (K Units)
Table 40. Americas Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2020-2025) & (K Units)
Table 41. APAC Opioid Induced Constipation (OIC) Drug Sales by Region (2020-2025) & (K Units)
Table 42. APAC Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2020-2025)
Table 43. APAC Opioid Induced Constipation (OIC) Drug Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Opioid Induced Constipation (OIC) Drug Sales by Type (2020-2025) & (K Units)
Table 45. APAC Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2020-2025) & (K Units)
Table 46. Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2025) & (K Units)
Table 47. Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2020-2025) & (K Units)
Table 49. Europe Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2020-2025) & (K Units)
Table 50. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2025) & (K Units)
Table 51. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Type (2020-2025) & (K Units)
Table 53. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2020-2025) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Opioid Induced Constipation (OIC) Drug
Table 55. Key Market Challenges & Risks of Opioid Induced Constipation (OIC) Drug
Table 56. Key Industry Trends of Opioid Induced Constipation (OIC) Drug
Table 57. Opioid Induced Constipation (OIC) Drug Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Opioid Induced Constipation (OIC) Drug Distributors List
Table 60. Opioid Induced Constipation (OIC) Drug Customer List
Table 61. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 62. Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 64. Americas Opioid Induced Constipation (OIC) Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Opioid Induced Constipation (OIC) Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 66. APAC Opioid Induced Constipation (OIC) Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Europe Opioid Induced Constipation (OIC) Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 70. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Type (2026-2031) & (K Units)
Table 72. Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Distribution Channel (2026-2031) & (K Units)
Table 74. Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Distribution Channel (2026-2031) & ($ millions)
Table 75. Ironwood Pharmaceuticals Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 76. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 77. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Ironwood Pharmaceuticals Main Business
Table 79. Ironwood Pharmaceuticals Latest Developments
Table 80. Daiichi Sankyo Co Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 81. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 82. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Daiichi Sankyo Co Main Business
Table 84. Daiichi Sankyo Co Latest Developments
Table 85. Pfizer Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 86. Pfizer Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 87. Pfizer Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Pfizer Main Business
Table 89. Pfizer Latest Developments
Table 90. Progenics Pharmaceuticals Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 91. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 92. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Progenics Pharmaceuticals Main Business
Table 94. Progenics Pharmaceuticals Latest Developments
Table 95. Shionogi & Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. Shionogi & Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 97. Shionogi & Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Shionogi & Main Business
Table 99. Shionogi & Latest Developments
Table 100. Allergan Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. Allergan Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 102. Allergan Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Allergan Main Business
Table 104. Allergan Latest Developments
Table 105. Nektar Therapeutics Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 106. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 107. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Nektar Therapeutics Main Business
Table 109. Nektar Therapeutics Latest Developments
Table 110. Purdue Pharma Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 111. Purdue Pharma Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 112. Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Purdue Pharma Main Business
Table 114. Purdue Pharma Latest Developments
Table 115. S.L.A. Pharma Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 116. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 117. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. S.L.A. Pharma Main Business
Table 119. S.L.A. Pharma Latest Developments
Table 120. Mundipharma International Limited Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 121. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 122. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Mundipharma International Limited Main Business
Table 124. Mundipharma International Limited Latest Developments
Table 125. Ono Pharmaceutical Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 126. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 127. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Ono Pharmaceutical Main Business
Table 129. Ono Pharmaceutical Latest Developments
Table 130. Takeda Pharmaceutical Company Limited Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 131. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 132. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Takeda Pharmaceutical Company Limited Main Business
Table 134. Takeda Pharmaceutical Company Limited Latest Developments
Table 135. Theravance Biopharma Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 136. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 137. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Theravance Biopharma Main Business
Table 139. Theravance Biopharma Latest Developments
Table 140. Bausch Health Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 141. Bausch Health Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 142. Bausch Health Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Bausch Health Main Business
Table 144. Bausch Health Latest Developments
Table 145. Cosmo Pharmaceuticals SA Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 146. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 147. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Cosmo Pharmaceuticals SA Main Business
Table 149. Cosmo Pharmaceuticals SA Latest Developments
Table 150. Daewoong Pharmaceutical Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 151. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 152. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Daewoong Pharmaceutical Main Business
Table 154. Daewoong Pharmaceutical Latest Developments
Table 155. C.B. Fleet Company Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 156. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 157. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. C.B. Fleet Company Main Business
Table 159. C.B. Fleet Company Latest Developments
Table 160. Sucampo Pharmaceuticals Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors
Table 161. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolios and Specifications
Table 162. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. Sucampo Pharmaceuticals Main Business
Table 164. Sucampo Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Opioid Induced Constipation (OIC) Drug
Figure 2. Opioid Induced Constipation (OIC) Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Opioid Induced Constipation (OIC) Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Opioid Induced Constipation (OIC) Drug Sales Market Share by Country/Region (2024)
Figure 10. Opioid Induced Constipation (OIC) Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Lubiprostone
Figure 12. Product Picture of Methyl Naltrexone Bromide
Figure 13. Product Picture of Naldemedine
Figure 14. Product Picture of Alvimopan
Figure 15. Product Picture of Other
Figure 16. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type in 2025
Figure 17. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2020-2025)
Figure 18. Opioid Induced Constipation (OIC) Drug Consumed in Hospital Pharmacies
Figure 19. Global Opioid Induced Constipation (OIC) Drug Market: Hospital Pharmacies (2020-2025) & (K Units)
Figure 20. Opioid Induced Constipation (OIC) Drug Consumed in Retail Pharmacies
Figure 21. Global Opioid Induced Constipation (OIC) Drug Market: Retail Pharmacies (2020-2025) & (K Units)
Figure 22. Opioid Induced Constipation (OIC) Drug Consumed in Online Pharmacies
Figure 23. Global Opioid Induced Constipation (OIC) Drug Market: Online Pharmacies (2020-2025) & (K Units)
Figure 24. Global Opioid Induced Constipation (OIC) Drug Sale Market Share by Distribution Channel (2024)
Figure 25. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel in 2025
Figure 26. Opioid Induced Constipation (OIC) Drug Sales by Company in 2025 (K Units)
Figure 27. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Company in 2025
Figure 28. Opioid Induced Constipation (OIC) Drug Revenue by Company in 2025 ($ millions)
Figure 29. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Company in 2025
Figure 30. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Opioid Induced Constipation (OIC) Drug Sales 2020-2025 (K Units)
Figure 33. Americas Opioid Induced Constipation (OIC) Drug Revenue 2020-2025 ($ millions)
Figure 34. APAC Opioid Induced Constipation (OIC) Drug Sales 2020-2025 (K Units)
Figure 35. APAC Opioid Induced Constipation (OIC) Drug Revenue 2020-2025 ($ millions)
Figure 36. Europe Opioid Induced Constipation (OIC) Drug Sales 2020-2025 (K Units)
Figure 37. Europe Opioid Induced Constipation (OIC) Drug Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales 2020-2025 (K Units)
Figure 39. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue 2020-2025 ($ millions)
Figure 40. Americas Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2025
Figure 41. Americas Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2020-2025)
Figure 42. Americas Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2020-2025)
Figure 43. Americas Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2020-2025)
Figure 44. United States Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Opioid Induced Constipation (OIC) Drug Sales Market Share by Region in 2025
Figure 49. APAC Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2020-2025)
Figure 50. APAC Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2020-2025)
Figure 51. APAC Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2020-2025)
Figure 52. China Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. India Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2025
Figure 60. Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2020-2025)
Figure 61. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2020-2025)
Figure 62. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2020-2025)
Figure 63. Germany Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 64. France Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2020-2025)
Figure 71. Egypt Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Opioid Induced Constipation (OIC) Drug in 2025
Figure 77. Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drug
Figure 78. Industry Chain Structure of Opioid Induced Constipation (OIC) Drug
Figure 79. Channels of Distribution
Figure 80. Global Opioid Induced Constipation (OIC) Drug Sales Market Forecast by Region (2026-2031)
Figure 81. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global Opioid Induced Constipation (OIC) Drug Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global Opioid Induced Constipation (OIC) Drug Sales Market Share Forecast by Distribution Channel (2026-2031)
Figure 85. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share Forecast by Distribution Channel (2026-2031)
Figure 1. Picture of Opioid Induced Constipation (OIC) Drug
Figure 2. Opioid Induced Constipation (OIC) Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Opioid Induced Constipation (OIC) Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Opioid Induced Constipation (OIC) Drug Sales Market Share by Country/Region (2024)
Figure 10. Opioid Induced Constipation (OIC) Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Lubiprostone
Figure 12. Product Picture of Methyl Naltrexone Bromide
Figure 13. Product Picture of Naldemedine
Figure 14. Product Picture of Alvimopan
Figure 15. Product Picture of Other
Figure 16. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type in 2025
Figure 17. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2020-2025)
Figure 18. Opioid Induced Constipation (OIC) Drug Consumed in Hospital Pharmacies
Figure 19. Global Opioid Induced Constipation (OIC) Drug Market: Hospital Pharmacies (2020-2025) & (K Units)
Figure 20. Opioid Induced Constipation (OIC) Drug Consumed in Retail Pharmacies
Figure 21. Global Opioid Induced Constipation (OIC) Drug Market: Retail Pharmacies (2020-2025) & (K Units)
Figure 22. Opioid Induced Constipation (OIC) Drug Consumed in Online Pharmacies
Figure 23. Global Opioid Induced Constipation (OIC) Drug Market: Online Pharmacies (2020-2025) & (K Units)
Figure 24. Global Opioid Induced Constipation (OIC) Drug Sale Market Share by Distribution Channel (2024)
Figure 25. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel in 2025
Figure 26. Opioid Induced Constipation (OIC) Drug Sales by Company in 2025 (K Units)
Figure 27. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Company in 2025
Figure 28. Opioid Induced Constipation (OIC) Drug Revenue by Company in 2025 ($ millions)
Figure 29. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Company in 2025
Figure 30. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Opioid Induced Constipation (OIC) Drug Sales 2020-2025 (K Units)
Figure 33. Americas Opioid Induced Constipation (OIC) Drug Revenue 2020-2025 ($ millions)
Figure 34. APAC Opioid Induced Constipation (OIC) Drug Sales 2020-2025 (K Units)
Figure 35. APAC Opioid Induced Constipation (OIC) Drug Revenue 2020-2025 ($ millions)
Figure 36. Europe Opioid Induced Constipation (OIC) Drug Sales 2020-2025 (K Units)
Figure 37. Europe Opioid Induced Constipation (OIC) Drug Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales 2020-2025 (K Units)
Figure 39. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue 2020-2025 ($ millions)
Figure 40. Americas Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2025
Figure 41. Americas Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2020-2025)
Figure 42. Americas Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2020-2025)
Figure 43. Americas Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2020-2025)
Figure 44. United States Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Opioid Induced Constipation (OIC) Drug Sales Market Share by Region in 2025
Figure 49. APAC Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2020-2025)
Figure 50. APAC Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2020-2025)
Figure 51. APAC Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2020-2025)
Figure 52. China Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. India Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2025
Figure 60. Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2020-2025)
Figure 61. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2020-2025)
Figure 62. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2020-2025)
Figure 63. Germany Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 64. France Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2020-2025)
Figure 71. Egypt Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Opioid Induced Constipation (OIC) Drug Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Opioid Induced Constipation (OIC) Drug in 2025
Figure 77. Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drug
Figure 78. Industry Chain Structure of Opioid Induced Constipation (OIC) Drug
Figure 79. Channels of Distribution
Figure 80. Global Opioid Induced Constipation (OIC) Drug Sales Market Forecast by Region (2026-2031)
Figure 81. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global Opioid Induced Constipation (OIC) Drug Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global Opioid Induced Constipation (OIC) Drug Sales Market Share Forecast by Distribution Channel (2026-2031)
Figure 85. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share Forecast by Distribution Channel (2026-2031)
